Rigel Pharmaceuticals
RIGL
#6807
Rank
โ‚น58.06 B
Marketcap
โ‚น3,199
Share price
-0.85%
Change (1 day)
74.68%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2025 (TTM): โ‚น10.53 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are โ‚น0.28 Billion. In 2024 the company made an earning of โ‚น2.41 Billion, an increase over its 2023 earnings that were of -โ‚น1.68 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น10.53 B336.94%
2024 โ‚น2.41 B-244.27%
2023 -โ‚น1.68 Billion-66.79%
2022 -โ‚น5.04 Billion340.73%
2021 -โ‚น1.15 Billion-56.15%
2020 -โ‚น2.61 Billion-57.34%
2019 -โ‚น6.11 Billion-7.66%
2018 -โ‚น6.62 Billion-9.47%
2017 -โ‚น7.31 Billion24.46%
2016 -โ‚น5.88 Billion23.63%
2015 -โ‚น4.75 Billion-43.29%
2014 -โ‚น8.38 Billion2.5%
2013 -โ‚น8.18 Billion
2010 โ‚น3.47 B-133.97%
2009 -โ‚น10.23 Billion-18.49%
2008 -โ‚น12.55 Billion71.91%
2007 -โ‚น7.3 Billion84.74%
2006 -โ‚น3.96 Billion-10.17%
2005 -โ‚น4.4 Billion-15.73%
2004 -โ‚น5.22 Billion39.29%
2003 -โ‚น3.75 Billion10.3%
2002 -โ‚น3.4 Billion48.3%
2001 -โ‚น2.3 Billion-2.13%
2000 -โ‚น2.35 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚น756.57 B 6,662.31%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.201 T 10,637.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-โ‚น10.01 Billion-189.43%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI
-โ‚น11.99 Billion-207.13%๐Ÿ‡บ๐Ÿ‡ธ USA